Biotechnology infographics | Labiotech https://www.labiotech.eu/infographics/ The European Biotech News Website Tue, 04 Apr 2023 13:46:09 +0000 en-US hourly 1 https://wordpress.org/?v=6.1.1 https://www.labiotech.eu/wp-content/uploads/2020/04/cropped-favicon-32x32.png Biotechnology infographics | Labiotech https://www.labiotech.eu/infographics/ 32 32 Infographic: Why choosing a client-centric CTDMO is critical when outsourcing biomanufacturing projects https://www.labiotech.eu/partner/ctdmo-biomanufacturing-biologics-merck/ https://www.labiotech.eu/partner/ctdmo-biomanufacturing-biologics-merck/#respond Tue, 28 Mar 2023 08:00:29 +0000 https://www.labiotech.eu/?p=106795 In 2021, 28% of FDA approvals were granted to biologic drugs, showcasing the increasing demand for the biopharma industry to develop, manufacture and market biologic-based therapies. Biologic drugs include monoclonal antibodies and large molecules produced in mammalian cells, bringing the already complex process of drug development to a new level. Although the biomanufacturing of many […]

The post Infographic: Why choosing a client-centric CTDMO is critical when outsourcing biomanufacturing projects appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/ctdmo-biomanufacturing-biologics-merck/feed/ 0
Infographic: your gene therapy manufacturing success recipe https://www.labiotech.eu/infographics/infographic-merck-gene-therapy-manufacturing-success/ https://www.labiotech.eu/infographics/infographic-merck-gene-therapy-manufacturing-success/#respond Mon, 14 Nov 2022 11:49:16 +0000 https://www.labiotech.eu/?p=109833 By 2026, pharma industry insiders anticipate cell and gene therapy sales to significantly increase, with a real potential for these therapies to overtake conventional drugs in the biomedical space. With more than 600 active global trials today, industry insiders predict that the market value for gene therapies alone will exceed a staggering $10B (€8.5B) by […]

The post Infographic: your gene therapy manufacturing success recipe appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/infographics/infographic-merck-gene-therapy-manufacturing-success/feed/ 0
Infographic: The biopharmaceutical factory of the future https://www.labiotech.eu/infographics/infographic-biopharmaceutical-factory-of-future/ https://www.labiotech.eu/infographics/infographic-biopharmaceutical-factory-of-future/#respond Tue, 11 Oct 2022 08:00:30 +0000 https://www.labiotech.eu/?p=84437 The biologics market is increasingly important and continues to grow. Hence, biopharmaceutical companies must adapt to meet the greater demand. The modernization of manufacturing processes and facilities is one way to do this. This infographic discusses how the Factory of the Future will transform the manufacture of biologics.  Download the infographic for free here! Biopharmaceutical […]

The post Infographic: The biopharmaceutical factory of the future appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/infographics/infographic-biopharmaceutical-factory-of-future/feed/ 0
How digital solutions are transforming biomanufacturing https://www.labiotech.eu/partner/digitalization-transforming-biomanufacturing/ https://www.labiotech.eu/partner/digitalization-transforming-biomanufacturing/#respond Tue, 04 Oct 2022 08:00:22 +0000 https://www.labiotech.eu/?p=91542 While biomanufacturers are experiencing immense pressure to increase productivity and deliver biotherapeutics to market faster, 70% of collected biomanufacturing data remains unused due to outdated, paper-based, and manual processes. Ultimately, this results in data loss and strongly contributes to the lengthy timelines and high costs of biologics drugs development. But digitalization can help! To optimize […]

The post How digital solutions are transforming biomanufacturing appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/digitalization-transforming-biomanufacturing/feed/ 0
Infographic: Drugging the Undruggable: Leveraging the Right Screening Methods for Challenging Targets https://www.labiotech.eu/partner/screening-methods-challenging-targets/ https://www.labiotech.eu/partner/screening-methods-challenging-targets/#respond Tue, 01 Mar 2022 09:00:00 +0000 https://www.labiotech.eu/?p=99935 Challenging targets, such as membrane proteins or protein-protein interactions were considered undruggable in the past. However, today a variety of screening methods can be used to help develop drugs against these formerly undruggable targets. Discover more in this infographic! There are thousands of challenging targets against which it is incredibly difficult to develop a drug. […]

The post Infographic: Drugging the Undruggable: Leveraging the Right Screening Methods for Challenging Targets appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/screening-methods-challenging-targets/feed/ 0
Gene therapy: Making Rare Disease Therapies Less Rare https://www.labiotech.eu/partner/gene-therapy-rare-disease-treatments/ https://www.labiotech.eu/partner/gene-therapy-rare-disease-treatments/#respond Mon, 15 Nov 2021 09:00:50 +0000 https://www.labiotech.eu/?p=99721 While individually uncommon, rare diseases collectively impact the lives of over 300 million people worldwide. Many rare conditions are chronic, progressive, and life-threatening with limited treatment options available. Advances in gene therapy provide hope to actual cures and could revolutionize treatment prospects for patients with rare genetic diseases.  This infographic shows how we can unlock […]

The post Gene therapy: Making Rare Disease Therapies Less Rare appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/gene-therapy-rare-disease-treatments/feed/ 0
Infographic: The Key Role of Imaging in Clinical Trials https://www.labiotech.eu/infographics/role-medical-imaging-techniques-clinical-trials/ https://www.labiotech.eu/infographics/role-medical-imaging-techniques-clinical-trials/#respond Tue, 26 Jan 2021 09:00:05 +0000 https://www.labiotech.eu/?p=83375 Medical imaging techniques, such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound have emerged as promising biomarkers in clinical trials. This brand new infographic, created in collaboration with Medpace, explores the different types of imaging techniques, their advantages, limitations, and how they can be successfully implemented in clinical trials.  The use of medical […]

The post Infographic: The Key Role of Imaging in Clinical Trials appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/infographics/role-medical-imaging-techniques-clinical-trials/feed/ 0
Ensuring Viral Vector Supply for Gene Therapies https://www.labiotech.eu/infographics/ensuring-viral-vector-supply-gene-therapies/ Mon, 26 Oct 2020 09:40:28 +0000 https://www.labiotech.eu/?p=80741 While the success of gene therapies has boosted investments in the sector, it has also led to a number of difficulties. In this new infographic, we discuss how gene therapy developers can ensure a sufficient viral vector supply, despite shortened development timelines other challenges. Compared to other biologics, such as antibodies, which take up to […]

The post Ensuring Viral Vector Supply for Gene Therapies appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
Infographic: How Can We Find an Effective Endometriosis Treatment? https://www.labiotech.eu/partner/searching-endometriosis-treatment/ Wed, 13 May 2020 13:30:59 +0000 https://www.labiotech.eu/?p=74112 The exact number of women suffering from endometriosis is unknown. However, it is estimated that 10% of women worldwide are affected. Endometriosis is a debilitating disease in which the endometrial cells that usually line the uterus are found in other regions of the body. Every month, as part of the menstrual cycle, the endometrial lining […]

The post Infographic: How Can We Find an Effective Endometriosis Treatment? appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
How to Overcome the Challenges in Biologics Development https://www.labiotech.eu/partner/challenges-biologics-development-quality-control/ Wed, 15 Apr 2020 08:00:08 +0000 https://www.labiotech.eu/?p=77729 By 2021, the global biologics market is expected to reach a value of $319B. But although they are currently celebrating a momentum, biologics development and quality control remain greatly challenging. To prevent severe immune reactions in patients that could trigger life-threatening conditions, these challenges need to be addressed.  Because of their great molecular complexity, the […]

The post How to Overcome the Challenges in Biologics Development appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
Gene Therapies: Overcoming the Biggest Hurdles in Manufacturing https://www.labiotech.eu/partner/gene-therapies-hurdles-manufacturing/ Mon, 16 Mar 2020 09:00:09 +0000 https://www.labiotech.eu/?p=77095 By 2024, the gene therapy market is expected to reach an estimated worth of $13B (€11.6B). With several therapies approved and hundreds of clinical trials underway, the sector is booming. However, its sudden and fast growth and the complexity of the therapy itself have resulted in a number of hurdles that need to be overcome. […]

The post Gene Therapies: Overcoming the Biggest Hurdles in Manufacturing appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
How Are Organoids Revolutionizing Cancer Drug Development? https://www.labiotech.eu/partner/organoids-cancer-drug-development/ Wed, 19 Feb 2020 09:00:38 +0000 https://www.labiotech.eu/?p=75178 Also known as ‘mini-organs in a dish’, organoids are defined as 3D structures that mimic the key functions of the corresponding organ or tissue in vivo. They are an exciting new alternative to the traditional tools of preclinical drug development, such as cell lines and animal models.  In preclinical drug development, organoids fulfill many functions […]

The post How Are Organoids Revolutionizing Cancer Drug Development? appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
Infographic: How Can Emerging Biotechs Best Tackle Upstream Process Development? https://www.labiotech.eu/partner/process-development-challenges-infographic/ Mon, 16 Dec 2019 09:00:19 +0000 https://www.labiotech.eu/?p=68178 During process development, emerging biotechs face a number of challenges. But what can they do to overcome these pitfalls and ensure successful outcomes later? Check out the brand new infographic below and discover the answers. You can also download a free version here. Get in touch with the team at BioReliance® End-to-End Solutions and get […]

The post Infographic: How Can Emerging Biotechs Best Tackle Upstream Process Development? appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
Infographic: How Can Biopharma Companies Best Prevent Prescription Drug Abuse? https://www.labiotech.eu/partner/infographic-biopharma-prevent-prescription-drug-abuse/ https://www.labiotech.eu/partner/infographic-biopharma-prevent-prescription-drug-abuse/#respond Mon, 09 Sep 2019 08:00:57 +0000 https://www.labiotech.eu/?p=64310 The misuse of prescription drugs for non-medical purposes has become an increasing problem worldwide. Together with Evotec, we have taken a look at how biopharma companies can prevent prescription drug abuse by taking drugs through strict assessment processes. Check out the new infographic below! You can also download a free version here! Are you struggling […]

The post Infographic: How Can Biopharma Companies Best Prevent Prescription Drug Abuse? appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/infographic-biopharma-prevent-prescription-drug-abuse/feed/ 0
Infographic: How to Increase the Success of Drug Development with Smart Design? https://www.labiotech.eu/partner/infographic-success-drug-development-smart-design/ https://www.labiotech.eu/partner/infographic-success-drug-development-smart-design/#respond Mon, 29 Jul 2019 12:30:54 +0000 https://www.labiotech.eu/?p=63676 Although failure rates in drug development are still quite high, a lot can be done to mitigate the risk. This brand new infographic shows how smart design can increase the chance of success for drug development candidates. Check it out below! You can also download a free version here! Want to know more? Get in […]

The post Infographic: How to Increase the Success of Drug Development with Smart Design? appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/infographic-success-drug-development-smart-design/feed/ 0
Infographic: The Importance of New Biological Drug Characterization https://www.labiotech.eu/infographics/infographic-biologic-drugs-characterization/ https://www.labiotech.eu/infographics/infographic-biologic-drugs-characterization/#respond Wed, 03 Apr 2019 10:00:39 +0000 https://www.labiotech.eu/?p=62112 By 2023, the monoclonal antibodies market is expected to reach a staggering $130B. The potential of monoclonal antibodies and other biologic drugs is huge. They are promising treatments for severe diseases and can improve or save patients’ lives. Check out our shiny new infographic on why these biologics need to be characterized properly! Download the […]

The post Infographic: The Importance of New Biological Drug Characterization appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/infographics/infographic-biologic-drugs-characterization/feed/ 0
Infographic: Unraveling the Complexity of Pediatric Dug Development https://www.labiotech.eu/infographics/infographic-pediatric-dug-development/ https://www.labiotech.eu/infographics/infographic-pediatric-dug-development/#respond Wed, 27 Mar 2019 09:00:24 +0000 https://www.labiotech.eu/?p=61657 Did you know that 50% of medications given to children are not even tested in children? You might be asking yourself why this is important. The answer is right here, in our colorful new and free infographic about pediatric clinical trials and pediatric drug development. Download the free infographic here! Want to learn more about […]

The post Infographic: Unraveling the Complexity of Pediatric Dug Development appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/infographics/infographic-pediatric-dug-development/feed/ 0
Infographic: The Basel Area Biotech & Pharma Ecosystem https://www.labiotech.eu/infographics/infographic-basel-area-biotech-ecosystem-baselaunch/ https://www.labiotech.eu/infographics/infographic-basel-area-biotech-ecosystem-baselaunch/#respond Wed, 30 Jan 2019 09:00:06 +0000 https://www.labiotech.eu/?p=60521 It takes an ecosystem to build a startup and world class innovation to build a good biotech company. And to develop a scientific discovery into a life-changing drug or technology, it takes experts from various fields. All of this and more can be found nestled between the borders of France and Germany, namely, in the […]

The post Infographic: The Basel Area Biotech & Pharma Ecosystem appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/infographics/infographic-basel-area-biotech-ecosystem-baselaunch/feed/ 0
Infographic: The Next Big Thing in Biological Drug Delivery https://www.labiotech.eu/infographics/infographic-oral-administration-biologics-amatsigroup/ https://www.labiotech.eu/infographics/infographic-oral-administration-biologics-amatsigroup/#respond Wed, 28 Nov 2018 09:05:11 +0000 https://www.labiotech.eu/?p=60646 By the year 2022, half of the top 100 drug sales will be biologics. And with 2,700 biologics currently in development, the market will soon be booming. But there is a hitch: Most biological drugs are administered parenterally. And though this is better than nothing, it does coincide with high treatment costs and stress for […]

The post Infographic: The Next Big Thing in Biological Drug Delivery appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/infographics/infographic-oral-administration-biologics-amatsigroup/feed/ 0
Infographic: All You Need to Know About Cultured Meat https://www.labiotech.eu/infographics/cultured-meat-infographic/ https://www.labiotech.eu/infographics/cultured-meat-infographic/#comments Mon, 02 Apr 2018 06:00:47 +0000 https://www.labiotech.eu/?p=56712 You might have heard about a new type of meat that can be produced without harming animals or harming the environment. This infographic will show you everything you need to know about cultured meat, which might be on your plate sooner than you think.  In the not-so-distant future, the vegan diet might include meat. Researchers […]

The post Infographic: All You Need to Know About Cultured Meat appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/infographics/cultured-meat-infographic/feed/ 4